The adipocyte anti-oncogene p19ARF is involved in the development of obesity and its metabolic complications

Key Points

• p19ARF plays a critical role in the obesity process, adding to the understanding of metabolic complications.
• The involvement of adipocyte oncogenes in obesity may influence future therapeutic strategies for metabolic disorders.
• Obesity-related metabolic complications highlight the need for deeper research into adipocyte functions.
• Understanding p19ARF could lead to innovative approaches targeting obesity and its effects on health.

Abstract